XBiotech Inc. Share Price

XBiotech Inc. Share Price

NASDAQ: XBIT | Micro Cap
$1.83
+$0.01 (0.55%) Last updated on 28 Oct, 2026 | 21:33 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

XBiotech Inc. Stock Performance

Open
$1.85
Prev. Close
$1.82
Circuit Range
N/A
Day Range
$1.85 - $1.85
Year Range
$1.82 - $3.43
Volume
545
Average Traded
$1.85

XBiotech Inc. Share Price Today

As of 29 October 2026, XBiotech Inc.'s share price is $1.83. The stock opened at $1.85, compared to its previous close of $1.82. During today's trading session, XBiotech Inc.'s share price traded between $1.85 and $1.85, with an average price of $1.85. Over the past 52 weeks, the stock has recorded a high of $3.43 and a low of $1.82. In terms of performance, XBiotech Inc.'s share price has declined by 27.95% over the last six months and is down 21.96% on a year-on-year basis.

XBiotech Inc. Share Price Chart

Line chart of the XBiotech Inc. price trend over the selected period. The price rose overall, ranging from 1.83 to 1.99, ending at 1.99.
$1.85$1.85
L
Show Current Price
H

XBiotech Inc. Stock Fundamentals & Key Indicators

Market Cap
$55.79M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.48
Revenue (TTM)
$0.00
Return On Equity (TTM)
-35.13%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-11.98%

XBiotech Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$6.01-$26.89-$5.51-$6.73
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-347.42%79.51%-22.14%

XBiotech Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$4.01$0.00$0.00$0.00
Net Profit-$32.90-$24.56-$38.53-$45.54
Net Profit Margin-820.45%N/AN/AN/A
Income ChangeN/A25.35%-56.88%-18.19%

About XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

XBiotech Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$2.19
$1.85
-16.10%
Sep 2026
$2.29
$2.21
-4.34%
Aug 2026
$2.25
$2.31
+2.44%
Jul 2026
$2.31
$2.25
-2.60%
Jun 2026
$2.43
$2.31
-5.33%
May 2026
$2.56
$2.44
-3.94%
Apr 2026
$2.31
$2.54
+8.09%
Mar 2026
$2.33
$2.35
+3.07%
Feb 2026
$2.60
$2.28
-9.16%
Jan 2026
$2.34
$2.51
+6.81%
Dec 2025
$2.37
$2.35
+3.98%
Nov 2025
$2.33
$2.26
-3.62%

XBIT Share Price FAQs